October 16, 2015
Eisai CEO Haruo Naito (right), Ajinomoto CEO Takaaki Nishii at News Conference on Oct. 15 Eisai and Ajinomoto have joined hands to establish what they hope to be the top specialty pharma for gastrointestinal (GI) diseases in Japan, announcing their...read more